- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da FDA Office of Orphan Products Development
Totale 141 risultati
-
University of MichiganCompletato
-
University of PennsylvaniaTerminatoMalattia da carenza di ornitina transcarbamilasi
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompletato
-
University of ArizonaFDA Office of Orphan Products DevelopmentTerminatoCoccidioidomicosiStati Uniti
-
NeuroHealing Pharmaceuticals Inc.FDA Office of Orphan Products DevelopmentSospeso
-
The Cleveland ClinicCompletato
-
FDA Office of Orphan Products DevelopmentBoston Children's HospitalCompletato
-
Johns Hopkins UniversityCompletatoEpilessia | Cisticercosi
-
Bellus Health IncFDA Office of Orphan Products DevelopmentCompletatoMalattie gastrointestinali | Malattie renali | Artrite reumatoide | Sindrome nevrotica | Amiloidosi secondaria (AA). | Sindrome mediterranea familiareStati Uniti, Israele, Finlandia, Francia, Italia, Lituania, Olanda, Polonia, Federazione Russa, Spagna, Tacchino, Regno Unito
-
Boston Children's HospitalFDA Office of Orphan Products DevelopmentAttivo, non reclutanteMalattia del trapianto contro l'ospite | MalignitàStati Uniti, Canada
-
Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products DevelopmentCompletatoIpercolesterolemia familiare omozigoteStati Uniti, Canada, Italia, Sud Africa
-
National Jewish HealthCompletatoInfezione da Mycobacterium Avium intracellulare
-
Johns Hopkins UniversityCompletato
-
Holles Laboratories, Inc.Completato
-
Boston Children's HospitalFDA Office of Orphan Products DevelopmentTerminato
-
Emmaus Medical, Inc.FDA Office of Orphan Products DevelopmentCompletatoAnemia falciforme | TalassemiaStati Uniti
-
IWK Health CentreCompletato
-
Ohio State UniversityCompletatoDistrofia muscolare, facioscapolo-omerale
-
FDA Office of Orphan Products DevelopmentLeadiant Biosciences, Inc.Completato
-
Boston Children's HospitalCompletatoAnemia falciformeStati Uniti
-
The Cleveland ClinicTerminato
-
Seattle Children's HospitalCompletatoDolore | Infante, neonato, malattie
-
Massachusetts General HospitalCompletato
-
FDA Office of Orphan Products DevelopmentUniversity of North CarolinaCompletato
-
Children's Hospital of PhiladelphiaCompletato
-
Children's Hospital of PhiladelphiaCompletato
-
Medical College of WisconsinFDA Office of Orphan Products DevelopmentTerminato
-
University of North CarolinaCompletato
-
FDA Office of Orphan Products DevelopmentChildren's Hospital of PhiladelphiaCompletato
-
University of North CarolinaCompletatoAnemia falciformeStati Uniti
-
FDA Office of Orphan Products DevelopmentUniversity of Massachusetts, WorcesterCompletatoArtrite reumatoide giovanile
-
University of North CarolinaCompletatoOsteoporosi | Fibrosi cisticaStati Uniti
-
FDA Office of Orphan Products DevelopmentCase Western Reserve UniversityCompletato
-
Children's Hospital Los AngelesCompletatoTrombosi | Trombocitopenia indotta da eparinaStati Uniti
-
Brigham and Women's HospitalCompletatoProtoporfiria eritropoietica
-
FDA Office of Orphan Products DevelopmentCase Western Reserve UniversityCompletato
-
Case Western Reserve UniversityTerminato
-
M.D. Anderson Cancer CenterCompletatoMalattie linfoproliferative | Leucemia | Neoplasie ematologiche | Leucemia, linfocitica, cronicaStati Uniti
-
Retina Foundation of the SouthwestCompletato
-
FDA Office of Orphan Products DevelopmentMedical University of South CarolinaCompletato
-
California Department of Health ServicesCompletatoBotulismo | Botulismo infantileStati Uniti
-
George BrewerFDA Office of Orphan Products DevelopmentCompletatoCirrosi Biliare PrimitivaStati Uniti
-
FDA Office of Orphan Products DevelopmentUniversity of Illinois at ChicagoCompletato
-
University of California, San DiegoCompletatoAcidosi latticaStati Uniti
-
Memorial Hospital of Rhode IslandCompletato
-
University of California, San FranciscoFDA Office of Orphan Products DevelopmentCompletatoPetto escavatoStati Uniti
-
University of California, San FranciscoFDA Office of Orphan Products DevelopmentTerminatoStudio di efficacia e sicurezza di Nexagon per difetti epiteliali corneali persistenti (NTX-PED-001)Difetti epiteliali corneali persistenti
-
State University of New YorkCompletato
-
State University of New YorkCompletatoContrattura di DupuytrenStati Uniti
-
Children's Hospital Medical Center, CincinnatiCompletato